Paper Details

  1. Home
  2. Paper Details

Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.

Author: AroraR, BatraS, MalhotraM, SharmaJ B, SharmaS

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

All three treatment combinations were found to be equally effective in the syndromic management of pelvic inflammatory disease. The cure rate was highest with ciprofloxacin and tinidazole, followed by the kit containing fluconazole, azithromycin, and secnidazole, and then doxycycline and metronidazole, but the differences were not statistically significant.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Pelvic inflammatory disease is a common problem faced by the gynecologists in there out patient department. AIM: The aim of the study was to evaluate the efficacy of three treatment combinations in the syndromic management of pelvic inflammatory disease in the out patient setting. SETTI...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14701947

データ提供：米国国立医学図書館（NLM）

Syndromic Management of Pelvic Inflammatory Disease: A Comparative Study of Three Treatment Combinations

This research examines a common challenge in gynecology: the management of pelvic inflammatory disease (PID). The authors conducted a prospective randomized controlled trial to evaluate the efficacy of three different treatment combinations in the syndromic management of PID in an outpatient setting.

Equal Efficacy: A Promising Outcome

The study's findings offer reassuring evidence for the effectiveness of multiple treatment combinations in managing PID. The researchers discovered that all three treatment groups demonstrated significant improvement in PID severity scores and cure rates, highlighting the potential for diverse treatment approaches. This discovery provides clinicians with greater flexibility in managing PID, enabling them to tailor treatment regimens to individual needs.

Improving the Management of PID

This research is like discovering a hidden oasis in the vast desert of PID management, offering multiple effective treatment options. The study's findings underscore the need for a personalized approach to managing PID, ensuring the best possible outcomes for patients. This research represents a significant step forward in understanding the diverse treatment options available for PID, potentially improving the lives of patients suffering from this challenging condition.

Dr.Camel's Conclusion

This research provides valuable insights into the effective management of PID, offering multiple treatment options with comparable outcomes. It's like finding a hidden spring in the vast desert of gynecological research, offering a source of revitalization and hope for patients seeking effective treatment for this debilitating condition. The study's findings pave the way for more personalized and effective treatment strategies, potentially improving the lives of patients suffering from PID.

Date :
  1. Date Completed 2005-01-05
  2. Date Revised 2020-05-15
Further Info :

Pubmed ID

14701947

DOI: Digital Object Identifier

14701947

Related Literature

Article Analysis
・Side Effects of tinidazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.